Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

This company has been marked as potentially delisted and may not be actively trading.

Regulus Therapeutics (RGLS) Insider Trading & Ownership

Regulus Therapeutics logo
Compare

Regulus Therapeutics (NASDAQ:RGLS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.35%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$171.17K
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$282.24K
Get RGLS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Regulus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

RGLS Insider Buying and Selling by Quarter

Regulus Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/3/2025Preston KlassenInsiderBuy12,000$7.99$95,880.00  
1/30/2025David BaltimoreDirectorBuy19,610$1.06$20,786.60  
1/30/2025Joseph P HaganCEOBuy50,000$1.09$54,500.00  
1/13/2025Christopher Ray AkerVPSell38,547$1.26$48,569.22  
1/13/2025Crispina CalsadaCFOSell38,716$1.26$48,782.16  
1/13/2025Joseph P HaganCEOSell115,290$1.26$145,265.40  
1/13/2025Preston KlassenInsiderSell31,445$1.26$39,620.70  
(Data available from 1/1/2013 forward)

RGLS Insider Trading Activity - Frequently Asked Questions

4.35% of Regulus Therapeutics stock is owned by insiders. Learn more on RGLS's insider holdings.

The following insiders have purchased RGLS shares in the last 24 months: David Baltimore ($20,786.60), Joseph P Hagan ($54,500.00), Kathryn J Collier ($7,280.00), and Preston Klassen ($95,880.00).

Insiders have purchased a total of 85,610 RGLS shares in the last 24 months for a total of $178,446.60 bought.

The following insiders have sold RGLS shares in the last 24 months: Christopher Ray Aker ($48,569.22), Crispina Calsada ($55,289.08), Joseph P Hagan ($162,615.60), and Preston Klassen ($39,620.70).

Insiders have sold a total of 244,046 Regulus Therapeutics shares in the last 24 months for a total of $306,094.60 sold.

Regulus Therapeutics Key Executives


Related Companies
Insider Tracking Tools
Insider Trading By Country
Latest Articles

This page (NASDAQ:RGLS) was last updated on 8/17/2025 by MarketBeat.com Staff
From Our Partners
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsored
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsored
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsored
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsored
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsored
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...
Brownstone Research | Sponsored